Lupin Digital Health and the American College of Cardiology partner to provide cardiovascular treatment at home

25 Jul 2023 , 11:43 AM

In a first-of-its-kind partnership, Lupin Digital Health and the American College of Cardiology (ACC) will work with Digital Therapeutics (DTx) to provide in-home cardiovascular treatment in India. This partnership intends to hasten the use and acceptance of DTx in cardiology in India. The Lyfe DTx platform from Lupin Digital Health seeks to help patients and their healthcare providers manage heart conditions at home, ensuring that patients stay healthy after leaving the hospital, and lower the rate of rehospitalization.

In order to assist medical professionals and carers, Lupin Digital Health will use the CardioSmart platform, recommendations, and workbooks from ACC. Through the Lyfe app and website from Lupin Digital Health, these resources will be available to medical professionals, patients, and carers.

According to Ami Bhatt, Chief Innovation Officer, ACC, who talked to ET, ‘this partnership with Lupin Digital Health reflects our commitment to advancing equitable cardiovascular care globally and demonstrates how innovative partnerships can deliver transformative outcomes for patients in India.’

Sidharth Srinivasan, CEO of Lupin Digital Health, emphasized the patient-centric approach of the partnership and stated, ‘The mounting burden of cardiovascular disease in India, affecting even the younger generation, makes this collaboration an urgent imperative.’

The American College of Cardiology will award certificates to cardiologists in recognition of their commitment to innovation and patient-centered healthcare in order to encourage the adoption of sophisticated digital technologies in cardiology. This partnership is essential for ensuring top-notch care and achieving better results in the convenience of patients’ homes.

For feedback and suggestions, write to us at [e-mail]